TY  - GEN
AU  - Cottu,Paul H
AU  - Bonneterre,Jacques
AU  - Varga,Andrea
AU  - Campone,Mario
AU  - Leary,Alexandra
AU  - Floquet,Anne
AU  - Berton-Rigaud,Dominique
AU  - Sablin,Marie-Paule
AU  - Lesoin,Anne
AU  - Rezai,Keyvan
AU  - Lokiec,François M
AU  - Lhomme,Catherine
AU  - Bosq,Jacques
AU  - Bexon,Alice S
AU  - Gilles,Erard M
AU  - Proniuk,Stefan
AU  - Dieras,Veronique
AU  - Jackson,David M
AU  - Zukiwski,Alexander
AU  - Italiano,Antoine
TI  - Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
SN  - 1932-6203
PY  - 2019///0319
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Delayed-Action Preparations
KW  - Female
KW  - Gonanes
KW  - Half-Life
KW  - Humans
KW  - Middle Aged
KW  - Nausea
KW  - etiology
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - Receptors, Progesterone
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0204973
ER  -